← All industries · Healthcare
Industry

Industrial Instruments For Measurement

Every analyzed stock in Industrial Instruments For Measurement — 17 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AME
AMETEK INC/
Deeply overvalued
Healthcare
Price$247.52
Model IV$174.79
P/IV1.40
Premium +42% Return to IV: -29.4%
Market implies +12.2%/yr vs model +9.2% · in line
CGNX
COGNEX CORP
Deeply overvalued
Healthcare
Price$60.91
Model IV$14.01
P/IV4.70
Premium +335% Return to IV: -77.0%
Market implies +24.7%/yr vs model +4.5% · above model
CLIR
ClearSign Technologies Corp
Undervalued
Healthcare
Price$3.11
Model IV$3.84
P/IV1.21
Discount 19% Return to IV: +23.5%
Market implies -5.9%/yr vs model +50.0% · below model
DHR
DANAHER CORP /DE/
Deeply overvalued
Healthcare
Price$217.46
Model IV$164.17
P/IV1.38
Premium +32% Return to IV: -24.5%
Market implies +9.6%/yr vs model +6.9% · in line
ELSE
ELECTRO SENSORS INC
Deeply overvalued
Healthcare
Price$7.74
Model IV$3.91
P/IV1.97
Premium +98% Return to IV: -49.5%
Market implies +9.8%/yr vs model +5.9% · above model
FCUV
FOCUS UNIVERSAL INC.
Valuation N/A
Healthcare
Price$4.44
Model IV—
P/IV—
Market implies +67.5%/yr
FTV
Fortive Corp
Fairly valued
Healthcare
Price$56.42
Model IV$54.14
P/IV1.03
Premium +4% Return to IV: -4.0%
Market implies +5.0%/yr vs model +5.3% · in line
HURC
HURCO COMPANIES INC
Undervalued
Healthcare
Price$21.06
Model IV$26.13
P/IV0.81
Discount 19% Return to IV: +24.1%
Market implies -1.2%/yr vs model +5.0% · below model
KEYS
Keysight Technologies, Inc.
Deeply overvalued
Healthcare
Price$374.67
Model IV$84.02
P/IV4.03
Premium +346% Return to IV: -77.6%
Market implies +27.0%/yr vs model +6.4% · above model
MKSI
MKS INC
Deeply overvalued
Healthcare
Price$260.38
Model IV$75.76
P/IV3.47
Premium +244% Return to IV: -70.9%
Market implies +26.6%/yr vs model +9.2% · above model
MLAB
MESA LABORATORIES INC /CO/
Overvalued
Healthcare
Price$126.06
Model IV$96.97
P/IV1.05
Premium +30% Return to IV: -23.1%
Market implies +14.3%/yr vs model +14.1% · in line
POAS
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
Valuation N/A
Healthcare
Price$0.14
Model IV—
P/IV—
Market implies +15.6%/yr vs model +15.0% · in line
RAL
Ralliant Corp
Deeply overvalued
Healthcare
Price$71.86
Model IV$39.42
P/IV1.78
Premium +82% Return to IV: -45.1%
Market implies +13.7%/yr vs model +6.4% · above model
ROP
ROPER TECHNOLOGIES INC
Deeply overvalued
Healthcare
Price$364.23
Model IV$172.77
P/IV2.12
Premium +111% Return to IV: -52.6%
Market implies +18.3%/yr vs model +10.9% · above model
SENS
Senseonics Holdings, Inc.
Valuation N/A
Healthcare
Price$9.02
Model IV—
P/IV—
Market implies +27.2%/yr
ST
Sensata Technologies Holding plc
Deeply overvalued
Healthcare
Price$42.23
Model IV$26.07
P/IV1.96
Premium +62% Return to IV: -38.3%
Market implies +11.5%/yr vs model +5.0% · above model
SYPR
SYPRIS SOLUTIONS INC
Deeply undervalued
Healthcare
Price$1.89
Model IV$6.71
P/IV0.49
Discount 72% Return to IV: +254.8%
Market implies -25.2%/yr vs model +5.3% · below model